Search

everythinglearnresearchcommunity

for

Search:↓

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Acitretin improved monilethrix symptoms temporarily, but they returned after stopping treatment.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

hsa_circ_0002980 can help stop liver cancer cells from growing and spreading.

Low-dose naltrexone helps improve symptoms and stabilize frontal fibrosing alopecia and lichen planopilaris.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

Long-term treatment with palbociclib plus letrozole maintains quality of life in certain breast cancer patients.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Baricitinib successfully treated severe hair loss.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Drugs targeting EMT molecules show promise for treating lichen planopilaris.

Trametinib can cause skin issues, but they can often be managed without stopping the drug.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

These new skin treatments are safer and more effective with minimal side effects.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

3D imaging effectively tracks skin changes in vitiligo treatment.

Lamotrigine can cause hair loss in some patients.

Baricitinib is the most effective treatment for alopecia areata.